| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |